Theriva Biologics's total assets for Q3 2024 were $40.11M, a decrease of -5.38% from the previous quarter. TOVX total liabilities were $15.47M for the fiscal quarter, a 4.94% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.